Results 21 to 30 of about 15,101 (253)
Journal of International Medical Research, 2021 Background Sorafenib is mainly used to treat patients with hepatocellular carcinoma (HCC) Barcelona Clinic Liver Cancer (BCLC) stage C, many of whom also have severe cirrhosis.
Jianting Zeng +5 more
doaj +1 more source
International Journal of Surgery, 2021 BACKGROUND Simultaneous splenectomy during liver transplantation is indicated for patients with cirrhosis complicated by severe hypersplenism, but disastrous procedure-related complications remain a special concern.
Lin Wei +8 more
semanticscholar +1 more source
Big spleens and hypersplenism: fix it or forget it?
Liver International, 2015 T. Boyer, S. Habib
exaly +2 more sources
World Journal of Gastroenterology, 2021 BACKGROUND The most effective treatment for advanced cirrhosis and portal hypertension is liver transplantation (LT). However, splenomegaly and hypersplenism can persist even after LT in patients with massive splenomegaly.
Wentao Jiang +6 more
semanticscholar +1 more source
Scientific Reports, 2021 To study the impact of total splenectomy (TS) on peripheral lymphocytes and their subsets in patients with hypersplenism associated with cirrhotic portal hypertension (CPH). We studied 102 consecutive patients who received TS from January 2008 to January
Y. Lv +5 more
semanticscholar +1 more source
Splenomegaly and Hypersplenism in Hepatic Vena Cava Syndrome
Hepatology Forum, 2021 Background and Aim: Hepatic vena cava syndrome (HVCS) is a bacterial infection-induced obliterative disease of the inferior vena cava at the site of the hepatic vein openings that causes chronic liver disease with a high incidence of liver cirrhosis and ...
S. Shrestha
semanticscholar +1 more source
Refractory chronic GVHD emerging after splenectomy in a marrow transplant recipient with accelerated phase CML [PDF]
, 2003 We report a 39-year-old female patient who underwent HLA-identical sibling allogeneic BMT for CML in accelerated phase. Severe pancytopenia refractory to G-CSF associated with progressive splenomegaly and RBC/ platelet transfusion dependency were present
Alan Belward +7 more
core +6 more sources
Annals of Translational Medicine, 2021 Background Whether hepatocellular carcinoma (HCC) patients with hypersplenism can benefit from splenectomy is unclear. This study aimed at exploring the efficacy and safety of concurrent splenectomy for HCC patients with hypersplenism.
Xue-Bing Shi +3 more
semanticscholar +1 more source
Idiopathic noncirrhotic portal hypertension: current perspectives [PDF]
, 2016 The term idiopathic noncirrhotic portal hypertension (INCPH) has been recently proposed to replace terms, such as hepatoportal sclerosis, idiopathic portal hypertension, incomplete septal cirrhosis, and nodular regenerative hyperplasia, used to describe ...
D'AMATI, Giulia +5 more
core +1 more source
Splenectomy before hepatectomy for patients with hepatocellular carcinoma and hypersplenism
Medicine, 2021 The spleen plays an important role in tumor progression and the curative effects of splenectomy before hepatectomy for hypersplenism and hepatocellular carcinoma (HCC) are not clear.
Chenyang Zhou +10 more
semanticscholar +1 more source